نتایج جستجو برای: ultrasound sonothrombolysis

تعداد نتایج: 108724  

Journal: :Stroke 2013
Andrew D Barreto Andrei V Alexandrov Loren Shen April Sisson Andrew W Bursaw Preeti Sahota Hui Peng Manouchehr Ardjomand-Hessabi Renganayaki Pandurengan Mohammad H Rahbar Kristian Barlinn Hari Indupuru Nicole R Gonzales Sean I Savitz James C Grotta

BACKGROUND AND PURPOSE The Combined Lysis of Thrombus in Brain Ischemia With Transcranial Ultrasound and Systemic T-PA-Hands-Free (CLOTBUST-HF) study is a first-in-human, National Institutes of Health-sponsored, multicenter, open-label, pilot safety trial of tissue-type plasminogen activator (tPA) plus a novel operator-independent ultrasound device in patients with ischemic stroke caused by pro...

Journal: :Stroke 2006
Matthias Reinhard Andreas Hetzel Sebastian Krüger Stefan Kretzer Jochen Talazko Sargon Ziyeh Johannes Weber Thomas Els

BACKGROUND AND PURPOSE A recent study showed a dramatic increase in cerebral hemorrhage comprising atypical locations with low-frequency ultrasound-mediated recombinant tissue plasminogen activator-thrombolysis in humans. Here, we provide a possible explanation for this phenomenon by a side effect observed in a study using the similar ultrasound device. METHODS The study was originally undert...

Journal: :Perspectives in Medicine 2012

2013
Thilo Hölscher Rema Raman David J Fisher Golnaz Ahadi Eyal Zadicario Arne Voie

The goal was to test the effects of various combinations of pulse widths (PW) and duty cycles (DC) on high-intensity focused ultrasound (HIFU)-induced sonothrombolysis efficacy using an in vitro flow model. An ExAblate™ 4000 HIFU headsystem (InSightec, Inc., Israel) was used. Artificial blood clots were placed into test tubes inside a human calvarium and exposed to pulsatile flow. Four differen...

Manijhe Mokhtari-Dizaji Masoud Mehrpour Mosayyeb Mobasheri Tayebeh Toliyat

Introduction: Stroke causes death and disability in patients throughout the world. At present, the only FDA- approved drug for ischemic stroke is recombinant tissue plasminogen activator (rt- PA). Unfortunately, rtPA can cause intracerebral hemorrhage and must use within limited time window (within 3-4.5 hour after onset of stroke). Ultrasound with rtPA loaded liposomes (rtPA_L...

Journal: :Physics in medicine and biology 2017
Christopher N Acconcia Ryan M Jones David E Goertz Meaghan A O'Reilly Kullervo Hynynen

It is well established that high intensity focused ultrasound can be used to disintegrate clots. This approach has the potential to rapidly and noninvasively resolve clot causing occlusions in cardiovascular diseases such as deep vein thrombosis (DVT). However, lack of an appropriate treatment monitoring tool is currently a limiting factor in its widespread adoption. Here we conduct cavitation ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید